CN Patent

CN1221417A — 具有抗糖尿病、降低血脂、抗高血压性能的噻唑烷二酮化合物,其制备方法及其药物组合物

Assigned to Dr Reddys Research Foundation · Expires 1999-06-30 · 27y expired

What this patent protects

本发明涉及新的抗糖尿病噻唑烷二酮化合物,其互变异构体,其衍生物,其立体异构体,其多晶型物,其可药用盐,其可药用溶剂化物及含它们的可药用组合物,制备抗糖尿病化合物的方法及其用途。

USPTO Abstract

本发明涉及新的抗糖尿病噻唑烷二酮化合物,其互变异构体,其衍生物,其立体异构体,其多晶型物,其可药用盐,其可药用溶剂化物及含它们的可药用组合物,制备抗糖尿病化合物的方法及其用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN1221417A
Jurisdiction
CN
Classification
—
Expires
1999-06-30
Drug substance claim
No
Drug product claim
No
Assignee
Dr Reddys Research Foundation
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.